Skip to Content

Arlene M. Correa, Ph.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Thoracic and Cardiovascular Surgery - Research, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Arlene M. Correa was born in San Juan, Puerto Rico.  She obtained her Master's degree in Mathematics at the University of Puerto Rico and her Ph.D. in Biometry with a minor in Epidemiology and Behavioral Sciences from The University of Texas - Houston Health Science Center, School of Public Health.  Dr. Correa joined  the Department of Thoracic and Cardiovascular Surgery at The University of Texas MD Anderson Cancer Center, in July 2000 as a Statistical Analyst and quickly excelled to the level of Instructor in August 2001.  Her expertise, drive and compassion let her ease through the ranks to Assistant Professor in September 2004 and Associate Professor in September 2011. 

Dr. Correa has been instrumental in the development, migration, and expansion of the department's clinical database.  She has also developed many sub-set databases and assists the faculty and fellows with research projects.  Her research interests are esophageal and lung cancer, and survival analysis. When she isn't working, she enjoys spending quality time with her family.

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 1489
Houston, TX 77030
Room Number: FCT19.5076
Phone: (713) 563-9145
Fax: (713) 794-4901

Education & Training

Degree-Granting Education

2000 The University of Texas - Houston Health Science Center, School of Public, Houston, TX, PHD, Biometry with minor in Epidemiology and Behavioral Sciences.
1995 University of Puerto Rico, Río Piedras, Puerto Rico, MS, Mathematics
1993 University of Puerto Rico, Río Piedras, Puerto Rico, BS, Mathematics
1991 University of Puerto Rico at Bayamón, Bayamón, Puerto Rico, AS, Mathematics

Postgraduate Training

8/1999-7/2000 Teaching Assistant, UT Health Science Center, Houston, TX, Dr. Jay Glasser
11/1996-8/1999 Graduate Research Assistant III, Center for Health Promotion Research and Development, School of Public Health, UT Health Science Center, Houston, TX, Dr. Maria E-Fernandez-Esquer
8/1995-5/1996 Statistics, 12 Ph.D. credits, The University of Texas at Dallas, Dallas, TX
6/1994-5/1995 Teaching Assistant, Department of Mathematics, University of Puerto Rico, Río Piedras, Puerto Rico, Dr. Pablo Salzberg
1/1994-5/1994 Teaching Assistant, Mathematics, University of Puerto Rico, Rio Piedras, Puerto Rico, Dr. Jorge Punchin
2/1993-12/1993 Research Assistant, Mathematics, University of Puerto Rico, Río Piedras, Puerto Rico, Dr. Pablo Salzberg
8/1992-12/1992 Precalculus Laboratory Instructor, Mathematics, University of Puerto Rico, Río Piedras, Puerto Rico, Dr. Phillip Pennance

Honors and Awards

2001 Delta Omega Honor Society
1999-2000 Richard D. Remington Scholarship
1993 Magna Cum Laude
1991-1993 Who's Who Among Students in American Universities & Colleges
1991 Magna Cum Laude
1991 Natural Sciences Medal
1989-1993 Dean's Honor Roll

Selected Publications

Peer-Reviewed Original Research Articles

1. Ganeshan DM, Bhosale P, Munden RF, Hofstetter WL, Correa AM, Iyer R. Diaphragmatic Hernia After Esophagectomy for Esophageal Malignancy. J Thorac Imaging 28(5):308-14, 9/2013. e-Pub 12/2012. PMID: 23222201.
2. Murphy CC, Hofstetter WL, Correa AM, Ajani JA, Komaki RU, Swisher SG. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Dis Esophagus 26(7):708-715, Sep-Oct, 9/2013. e-Pub 1/2013. PMID: 23350713.
3. Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery. Ann Surg Oncol 20(6):1934-40, 6/2013. e-Pub 12/2012. PMCID: PMC3656229.
4. William WN, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, University of Texas M.D. Anderson Lung Cancer Collaborative Research Group. Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant Chemotherapy. J Thorac Oncol 8(2):222-8, 2/2013. PMCID: PMC3549050.
5. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 94(6):1802-9, 12/2012. e-Pub 10/2012. PMID: 23063195.
6. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 10/2012. e-Pub 7/2012. PMCID: PMC3457750.
7. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg 94(4):1104-11; discussion 1111-3, 10/2012. e-Pub 8/2012. PMID: 22939245.
8. Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Ann Thorac Surg 94(4):1079-84; discussion 1084-5, 10/2012. e-Pub 7/2012. PMCID: PMC3466075.
9. Swisher S, Ajani J, Correa A, Komaki R, Hofstetter W. Minimally invasive versus open oesophagectomy for oesophageal cancer. Lancet 380(9845):883; author reply 885-6, 9/2012. PMID: 22959377.
10. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-22, Sep-Oct, 9/2012. e-Pub 12/2011. PMID: 22150920.
11. He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One 7(2):e31087, 2012. e-Pub 2/2012. PMCID: PMC3277494.
12. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 2012. e-Pub 9/2012. PMID: 22964903.
13. Hu Y, Correa AM , Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128(1):132-43, 1/2011. PMCID: PMC2937084.
14. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 12/2010. e-Pub 11/2010. PMID: 21136578.
15. Pataer A, Raso MG, Correa AM Behrens C, Tsuta K, Solis L, Fang B, Roth JA, Wistuba II, Swisher SG. Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients. Clin Cancer Res 16(22):5522-8, 11/2010. e-Pub 10/2010. PMID: 20930042.
16. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group and the University of Rochester School of Medicine and Dentistry Foregut Group. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 10/2010. PMID: 20881767.
17. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-899, 9/2010. PMID: 20732514.
18. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status. Ann Thorac Surg 90(3):884-891, 9/2010. PMID: 20732513.
19. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 7/2010. PMID: 20609777.
20. Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg 89(6):1797-1803, 1804.e1-3; discussion 1803-4, 6/2010. PMID: 20494031.
21. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/2010. PMID: 20143431.
22. Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol 22(12):1612-21, 12/2009. e-Pub 9/2009. PMID: 19734842.
23. Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-8, 10/2009. e-Pub 6/2009. PMID: 19562780.
24. Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115(19):4564-75, 10/2009. PMID: 19670455.
25. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 10/2009. e-Pub 4/2009. PMID: 19660349.
26. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 9/2009. PMID: 19699915.
27. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 8/2009. e-Pub 5/2009. PMCID: PMC2731793.
28. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 75(7):598-603; discussion 603-4, 7/2009. PMID: 19655604.
29. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 6/2009. PMID: 19464452.
30. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 4/2009. PMID: 19156915.
31. Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran C, Singh H, Vaporciyan AA, Reardon M. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87(3):977-984, 3/2009. PMID: 19231448.
32. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal tumor length is independently associated with long-term survival. Cancer 115(3):508-16, 2/2009. PMID: 19117343.
33. Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 11/2008. PMID: 19021684.
34. Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer 113(6):1302-1308, 9/2008. PMID: 18623381.
35. Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 9/2008. PMID: 18670347.
36. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 112(5):1020-7, 3/2008. PMID: 18205187.
37. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 112(3):503-10, 2/2008. PMID: 18072264.
38. Agarwal B, Correa AM, Ho L. Survival in pancreatic carcinoma based on tumor size. Pancreas 36(1):e15-20, 1/2008. PMID: 18192868.
39. Deus HF, Stanislaus R, Veiga DF, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Chang A, Vogel LH, Almeida JS. A Semantic Web management model for integrative biomedical informatics. PLoS One 3(8):e2946, 2008. PMCID: PMC2491554.
40. Blackmon SH, Patel AR, Bruckner BA, Beyer EA, Rice DC, Vaporciyan AA, Wojciechowski Z, Correa AM, Reardon MJ. Cardiac autotransplantation for malignant or complex primary left-heart tumors. Tex Heart Inst J 35(3):296-300, 2008. PMCID: PMC2565530.
41. Tetzlaff ED, Correa AM, Komaki R, Swisher SG, Maru D, Ross WA, Ajani JA. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction. Dis Esophagus 22(7):575-81, 2008. e-Pub 5/2008. PMID: 18459989.
42. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-8, 11/2007. PMID: 17975494.
43. Abraham SC, Krasinskas AM,Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TT. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 31(11):1719-25, 11/2007. PMID: 18059229.
44. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-92; discussion 1692-3, 11/2007. PMID: 17954086.
45. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69(2):350-7, 10/2007. PMID: 17467922.
46. Ajani JA, Correa AM, Swisher SG, Wu TT. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens? J Clin Oncol 25(27):4315-6, 9/2007. PMID: 17878485.
47. Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 84(3):973-80, 9/2007. PMID: 17720411.
48. Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg 84(3):982-6, 9/2007. PMID: 17720413.
49. Izzo JG, Luthra R, Sims-Mourtada J, Chao KSC, Lee JH, Wu TT, Correa AM, Luthra M, Aggarwal B, Hung MC, Ajani JA. Emerging molecular targets in esophageal cancers. Gastrointest Cancer Res 1(4 (Supplement 2)):S3-S6, 8/2007.
50. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365-73; discussion 374-5, 8/2007. PMID: 17643602.
51. Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JA. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev 16(6):1200-5, 6/2007. PMID: 17548685.
52. Blackmon SH, Correa AM , Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 83(5):1805-13; discussion 1813, 5/2007. PMID: 17462404.
53. Tetzlaff ED, Correa AM , Baker J, Ensor J, Ajani JA. The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma. Cancer 109(10):1989-95, 5/2007. PMID: 17397035.
54. Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN, Ajani JA. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 25(6):698-707, 2/2007. PMID: 17308274.
55. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2/2007. PMID: 17211865.
56. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109(1):125-34, 1/2007. PMID: 17146785.
57. Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31(1):58-64, 1/2007. PMID: 17197919.
Other Articles
1. Deus HF, Stanislaus R, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Almeida JS. Data driven semantic integration of translational lung cancer research at M D Anderson Cancer Center. AMIA Annu Symp Proc:927, 2008. PMID: 18999102.
2. Izzo JG, Luthra R, Wu TT, Correa AM, Luthra M, Anandasabapathy S, Chao KS, Hung MC, Aggarwal B, Hittelman WN, Ajani JA. Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol 34(2 Suppl 1):S2-6, 4/2007. PMID: 17449347.

Last updated: 4/21/2015